Lonza Group AG

Pharmaceuticals
Switzerland
Executive 1Richard Ridinger, Chief Executive Officer; | Chief Executive Officer;
Executive 2Toralf Haag, Chief Financial Officer; | Executive Vice President; ; Chief Financial Office
Earnings Per Share Growth (%)173.05%
Cost of Goods Sold (US$ Millions)$2,594
Current Liabilities (US$ Millions)$1,569
Total Assets (US$ Millions)$1,896
Long Term Debt (Millions)$1,712
Return on Equity11.15%
Revenue (US$ Millions)$3,725
Total Company Assets$6,511
Revenue Growth (%)1.60%
Net Income (US$ Millions)$240
Earnings Per Share (US$)$4.61
Total Equity (US$ Millions)$2,153
Profit Margin (%)6.43%
Debt To Equity Ratio (%)0.79%
Inventories (Millions)$908